Business
Verici Dx - Intention to admit to trading on AIM
Verici Dx - Intention to admit to trading on AIM.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 9631B\n Renalytix AI PLC\n 13 October 2020\n \n \n \n \n Not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States, Australia, Canada, Hong Kong, Japan, New Zealand, the Republic of South Africa or any other jurisdiction where it is unlawful to distribute this announcement.\n \n \n \n \n \n \n \n 13 October 2020\n \n \n \n \n Verici Dx plc\n \n \n (\"Verici Dx\" or the \"Company\") \n \n \n \n \n \n Intention to admit to trading on AIM\n \n \n Proposed placing, subscription and a Restricted Offer\n \n \n Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant, announces that it intends to apply to have its issued share capital, as enlarged by a proposed placing, subscription and a Restricted Offer (as defined below) (together, the \"Fundraising\"), admitted to trading on AIM in due course (\"Admission\").\n \n \n \n \n This announcement follows on from recent updates provided by Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), on 2 September 2020 and 8 July 2020, and this release is being linked to the RENX ticker for information purposes only.\n \n \n \n \n The Company is pleased to confirm that it intends to launch a restricted offer as part of the Fundraising. The restricted offer will enable certain qualifying Company shareholders in the UK to subscribe for ordinary shares in the Company (\"Verici Shares\") (the \"Restricted Offer\") on the same terms and at the same price per share as participants in the placing and subscription.\n \n \n \n \n \n The Restricted Offer is only available to certain persons, being persons who held the beneficial title to any A Shares of £0.001 each in the capital of the Company on 10 July 2020 (the \"Record Date\") whose registered address is in the UK (\"Qualifying Shareholders\") (being persons recorded on the register of members of Renalytix AI plc on 9 July 2020). This document sets out further details of the Restricted Offer.\n \n \n \n \n \n \n Full details of the Restricted Offer can be found in the Pathfinder (draft) Admission Document (\n \n \"Pathfinder\") available online to Qualifying Shareholders only at\n \n www.vericidx.com\n \n . \n \n \n \n \n \n Please note that the \n Pathfinder\n Admiss...